Bioequivalence evaluation of epinephrine autoinjectors with attention to rapid delivery

Therapeutics and Clinical Risk Management

Volumn 9, Issue 1, 2013, Pages 149-151

  Sclar, David Alexander ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Anaphylaxis; Bioavailability; Epipen; Pharmacokinetics; Tmax; Therapy

Indexed keywords

ADRENALIN;

AREA UNDER THE CURVE; ARTICLE; AUTOINJECTOR; BIOEQUIVALENCE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; MAXIMUM PLASMA CONCENTRATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84877898407     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S43774     Document Type: Article

References (10)

1. Simons FE. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124(4):625-636.
2. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125(2 Suppl 2): S161-S181.
3. Simons FE, Sheikh A. Anaphylaxis: the acute episode and beyond. BMJ. 2013;346:f602.
4. Sclar DA. Economic burden of anaphylaxis in the United States. Poster presented at: Eastern Allergy Conference; May 31-June 3, 2012. Palm Beach, FL, USA.
5. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-873.
6. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150.
7. Center for Drug Evaluation and Research. Application Number: 201739Orig1s000. Clinical Pharmacology and Biopharmaceutics Review(s). Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/201739Orig1s000Cl inPharmR.pdf. Accessed February 1, 2013.
8. Center for Drug Evaluation and Research. Application Number: 201739Orig1s000. Medical Review(s). Available from: http://www. accessdata.fda.gov/drugsatfda_docs/nda/2012/201739Orig1s000MedR.pdf. Accessed February 1, 2013.
9. Haidar SH, Davit B, Chen ML, et al. Bioequivalence approaches for highly variable drugs and drug products. Pharm Res. 2008;25(1):237-241.
10. Edwards ES, Gunn R, Simons FE., et al. Epinephrine 0.3 mg bioavailability following a single injection with a novel epinephrine auto-injector, e-cue tm, in healthy adults, with reference to a single injection using EpiPen 0.3 mg [abstract]. J Allergy Clin Immunol. 2012; 129(Suppl 2):AB179. Available from: http://download.journals.elsevierhealth.com/pdfs/journals/0091-6749/PIIS 009167491102197X.pdf. Accessed February 1, 2012.